PROFFERED PAPERS
Monday, February 28   —  8:00 AM   —  Convention Center Room 203


Click on the numbers in parentheses to display abstracts.



Section H1 - NEUROPATHOLOGY
Chaired by: Gregory N. Fuller and Arie Perry



8:00 Inflammatory Myofibroblastic Tumors in the CNS and Respiratory Tract: A Comparative Analysis (1364)
RS Swain, AE Horvai, M Loda, PC Burger, BW Scheithauer, T Tihan, GE Kim - UCSF, San Francisco, CA; Dana-Farber Cancer Institute, Boston, MA; Johns Hopkins, Baltimore, MD; Mayo Clinic, Rochester, MN
8:15 BAF47/INI1/hSNF5 Expression Is Retained in Composite Rhabdoid Tumors, Including Rhabdoid Meningiomas (1356)
A Perry, CE Fuller, AR Judkins, LP Dehner, JA Biegel - Washington University School of Medicine, St. Louis, MO; St Jude Children's Research Hospital, Memphis, TN; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA
8:30 Anaplastic Oligodendroglioma: Distinctive Morphologic and Immunophenotypic Subsets Associated with Combined 1p/19q Allelic Loss (1361)
RR Seethala, T Ribalta, KD Aldape, JM McDonald, GN Fuller - University of Texas, M. D. Anderson Cancer Center, Houston, TX; Institut d'Investigacions Biomediques August Pi i Suntilder (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
8:45 Aquaporin 1 Distinguishes Hemangioblastoma from Metastatic Renal Cell Carcinoma (1354)
E Orvieto, L Laurino, S Rossi, A Furlanetto, F Canal, AP Dei Tos Hospital of Treviso, Treviso, Italy
9:00 Beta-Catenin Is Expressed Consistently in Meningiomas: Another Link in the Chain of "BROCN"-Family of Tumors? (1355)
V Pansare, O Basturk, W Kupsky, E Levi, P Tabaczka, JD Cheng, NV Adsay - Wayne State University, MI
9:15 Patterns of Constitutive Activation of Signal Transducers and Activators of Transcription 3 and 5 (STAT3 and STAT5) in Primary CNS Lymphomas (PCNSL) (1349)
P Iorga, G Owor, T Nazeer, XH Yang, CE Sheehan, JS Ross, J Qian - Albany Medical College, Albany, NY
9:30 RECESS, EXHIBITS, POSTER SESSION I